112 related articles for article (PubMed ID: 18278469)
21. Exploration of molecular mechanisms of diffuse large B-cell lymphoma development using a microarray.
Zhang ZX; Shen CF; Zou WH; Shou LH; Zhang HY; Jin WJ
Asian Pac J Cancer Prev; 2013; 14(3):1731-5. PubMed ID: 23679265
[TBL] [Abstract][Full Text] [Related]
22. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
23. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
[TBL] [Abstract][Full Text] [Related]
24. Expression of TMEM87B interacting with the human papillomavirus type 18 E6 oncogene in the Hela cDNA library by a yeast two-hybrid system.
Li S; Liu P; Xi L; Jiang X; Wu M; Deng D; Wei J; Zhu T; Zhou L; Wang S; Xu G; Meng L; Zhou J; Ma D
Oncol Rep; 2008 Aug; 20(2):421-7. PubMed ID: 18636207
[TBL] [Abstract][Full Text] [Related]
25. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
[TBL] [Abstract][Full Text] [Related]
26. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
27. A Preliminary Study on Metadherin as a Potential Marker for Progression of Diffuse Large B Cell Lymphoma.
Ge X; Sui X; Fang X; Jiang Y; Ding M; Liu X; Wang X
Genet Test Mol Biomarkers; 2018 Aug; 22(8):481-486. PubMed ID: 30117777
[TBL] [Abstract][Full Text] [Related]
28. Serotonin receptor 3A expression in normal and neoplastic B cells.
Rinaldi A; Chiaravalli AM; Mian M; Zucca E; Tibiletti MG; Capella C; Bertoni F
Pathobiology; 2010; 77(3):129-35. PubMed ID: 20516728
[TBL] [Abstract][Full Text] [Related]
29. A circular RNA from
Hu Y; Zhao Y; Shi C; Ren P; Wei B; Guo Y; Ma J
Aging (Albany NY); 2019 Oct; 11(19):8068-8084. PubMed ID: 31631067
[TBL] [Abstract][Full Text] [Related]
30. Isolation of novel differentially expressed genes related to human glioma using cDNA microarray and characterizations of two novel full-length genes.
Qi ZY; Li Y; Ying K; Wu CQ; Tang R; Zhou ZX; Chen ZP; Hui GZ; Xie Y
J Neurooncol; 2002 Feb; 56(3):197-208. PubMed ID: 12061725
[TBL] [Abstract][Full Text] [Related]
31. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol.
Lam LT; Pickeral OK; Peng AC; Rosenwald A; Hurt EM; Giltnane JM; Averett LM; Zhao H; Davis RE; Sathyamoorthy M; Wahl LM; Harris ED; Mikovits JA; Monks AP; Hollingshead MG; Sausville EA; Staudt LM
Genome Biol; 2001; 2(10):RESEARCH0041. PubMed ID: 11597333
[TBL] [Abstract][Full Text] [Related]
32. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
[TBL] [Abstract][Full Text] [Related]
33. [Identify the Molecular Target of Diffuse Large B Cell Lymphoma by Bioinformatics Analysis].
Zhou Y; He S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1585-1591. PubMed ID: 33067958
[TBL] [Abstract][Full Text] [Related]
34. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
[TBL] [Abstract][Full Text] [Related]
35. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
36. MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
Liggins AP; Cooper CD; Lawrie CH; Brown PJ; Collins GP; Hatton CS; Pulford K; Banham AH
Br J Haematol; 2007 Aug; 138(4):479-86. PubMed ID: 17608765
[TBL] [Abstract][Full Text] [Related]
37. Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma.
Chang KC; Chen RY; Wang YC; Hung LY; Medeiros LJ; Chen YP; Chen TY; Yang JC; Chiang PM
Sci Rep; 2020 Dec; 10(1):21342. PubMed ID: 33288848
[TBL] [Abstract][Full Text] [Related]
38. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis of differentially expressed miRNA-related mRNAs and their prognostic value in breast carcinoma.
Zhang GM; Goyal H; Song LL
Oncol Rep; 2018 Jun; 39(6):2865-2872. PubMed ID: 29693181
[TBL] [Abstract][Full Text] [Related]
40. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
